Q-Pharm maintains a strategic relationship with Australian bio-analytical laboratory, TetraQ Research Infrastructure Centre (www.tetraq.com.au), who provide comprehensive drug analysis capabilities to support complex pharmacokinetic studies in the broad range of early phase trials conducted at Q-Pharm. Q-Pharm also collaborates with external pathology providers for electronic reporting of a variety of other laboratory testing requirements.

The co-location of Q-Pharm and TetraQ within the campus of the Royal Brisbane and Women's Hospital facilitates rapid turnaround of pharmacokinetic results for studies that require PK data for dose escalation decisions and safety review committees.

TetraQ and other pathology partners are NATA accredited for both GLP and compliance with ISO/IEC 17025 and provide analytical services acceptable in any regulatory domain.